BMP-4 peptides and methods of use

Patent metadata

Field	Value
Publication number	US-9951112-B2
Application number	US-201113636870-A
Country	US
Kind code	B2
Filing date	Mar 24, 2011
Priority date	Mar 24, 2010
Publication date	Apr 24, 2018
Grant date	Apr 24, 2018

Abstract

The invention relates to truncated BMP-4 growth factors and variants thereof. The invention also relates to methods of making and using the truncated BMP-4 growth factors.

First claim

What is claimed is:

1. A composition comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 2, and at least one protease selected from the group consisting of collagenase, dispase, and a mixture thereof.

2. The composition according to claim 1 , wherein the at least one protease consists of collagenase.

3. The composition of claim 1 , wherein the at least one protease consists of dispase.

4. The composition of claim 1 , wherein the at least one protease consists of collagenase and dispase.

5. The composition according to claim 1 , wherein the concentration of the peptide is about 30 ng/mL or less.

6. The composition according to claim 1 , wherein the concentration of the peptide is about 10 ng/mL or less.

7. The composition of claim 1 , further comprising
at least one pharmaceutically acceptable carrier.

8. The composition according to claim 7 , wherein the pharmaceutically acceptable carrier is selected from the group consisting of saline, Ringer's solution, dextrose solution, 5% human serum albumin, dispersion media, coatings, antibacterial and antifungal agents, and isotonic and absorption delaying agents.

9. A method of promoting differentiation of cells into osteoblasts or chondrocytes, the method comprising treating the cells with the composition of claim 1 in an amount effective to promote the differentiation, wherein the cells are progenitor cells, adult stem cells, or induced pluripotent stem cells.

10. The method of claim 9 , wherein the cells are progenitor cells or adult stem cells.

11. The method of claim 10 , wherein the progenitor cells or the adult stem cells are derived from placenta, bone marrow, adipose tissue, blood vessel, amniotic fluid, synovial fluid, synovial membrane, pericardium, periosteum, dura, peripheral blood, umbilical blood, menstrual blood, baby teeth, nucleus pulposus, brain, skin, hair follicle, intestinal crypt, neural tissue, or muscle.

12. The method of claim 9 , wherein the cells are induced pluripotent stem cells.

13. A method of promoting osteogenesis in a tissue, the method comprising treating the tissue with the composition of claim 1 in an amount effective to promote the osteogenesis in the tissue, wherein the tissue is a bone tissue.

14. The method of claim 13 , wherein the osteogenic activity of cells in the treated tissue is greater than the osteogenic activity of cells in untreated tissue.

15. A method of increasing a cellular growth factor activity in cells, the method comprising treating the cells with the composition of claim 1 in an amount effective to increase the cellular growth factor activity in the cells, wherein the cells are progenitor cells, adult stem cells, or induced pluripotent stem cells, and wherein the cellular growth factor activity is osteoinductive activity, chondroinductive activity, or a combination thereof.

16. The method according to claim 15 , wherein the cells are progenitor cells or adult stem cells.

17. The method according to claim 16 , wherein the progenitor cells or the adult stem cells are derived from placenta, bone marrow, adipose tissue, blood vessel, amniotic fluid, synovial fluid, synovial membrane, pericardium, periosteum, dura, peripheral blood, umbilical blood, menstrual blood, baby teeth, nucleus pulposus, brain, skin, hair follicle, intestinal crypt, neural tissue, or muscle.

18. The method according to claim 15 , wherein the cells are induced pluripotent stem cells.

19. The method according to claim 15 , wherein the composition comprises two or more proteases.

20. The method according to claim 19 , wherein the composition comprises (a) a first protease selected from the group consisting of collagenase, clostripain, dispase, trypsin, MMP-13 (matrix metalloproteinase-13), and a mixture thereof, and (b) a second protease selected from the group consisting of collagenase, clostripain, dispase, trypsin, BMP-1 (bone morphogenetic protein-1), MMP-13 (matrix metalloproteinase-13), and a mixture thereof, and wherein the first and second proteases are different.

21. The method according to claim 15 , wherein the at least one protease is collagenase.

22. A method of growing and/or culturing cells comprising:
growing and/or culturing cells in the presence of the composition of claim 1 .

23. The method according to claim 22 , wherein the cells are selected from the group consisting of mesenchymal stem cells, adipose-derived stem cells, embryonic stem cells, progenitor cells, differentiated cells, undifferentiated cells, and induced pluripotent stem cells.

24. A method of making the composition of claim 1 , comprising preparing said peptide by contacting mature BMP-4 with collagenase under conditions that promote protein cleavage to produce the peptide and harvesting the peptide, and
mixing the peptide with at least one pharmaceutically acceptable carrier and the at least one protease, whereby the composition of claim 1 is prepared.

25. A method of making the composition of claim 1 , comprising
preparing said peptide by culturing a host cell under conditions suitable for protein expression, wherein the host cell comprises a vector that encodes said peptide,
harvesting the peptide, and
mixing the peptide with the at least one protease, whereby the composition of claim 1 is prepared.

Assignees

• Qin Xiaofei
• Chen Silvia
• Chen Jingsong
• Clagett James
• Lifenet Health

Inventors

• Qin Xiaofei
• Chen Silvia
• Chen Jingsong
• Clagett James

Classifications

• A61P19/08

  for bone diseases, e.g. rachitism, Paget's disease · CPC title

• A61P19/00

  Drugs for skeletal disorders · CPC title

• C12N5/0602

  Vertebrate cells · CPC title

• A61K38/48

  acting on peptide bonds (3.4) · CPC title

• C12N2501/155

  Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor · CPC title